Bioavailability of intranasal formulations of dihydroergotamine.

P.H.M. van der Kuy,Jjhm Lohman,P. M. Hooymans,J W M ter Berg,F. W. H. M. Merkus

Bioavailability of intranasal formulations of dihydroergotamine.

1999

P.H.M. van der Kuy
Jjhm Lohman
P. M. Hooymans
J W M ter Berg
F. W. H. M. Merkus

Objective: A comparison of the pharmacokinetic properties of two novel intranasal preparations of dihydroergotamine mesilate (DHEM) with a commercially available intranasal preparation.

Keywords:

Anesthesia
Excipient
Nasal administration
Medicine
Oral administration
Ergot Derivatives
Dihydroergotamine
Bioavailability
Dosage form
Pharmacology
Pharmacokinetics
pharmacology toxicology
α adrenergic receptors

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations